Patient and Facility Characteristics Associated With Benzodiazepine Prescribing for Veterans With PTSD
- 1 February 2013
- journal article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 64 (2), 149-155
- https://doi.org/10.1176/appi.ps.201200267
Abstract
Practice guidelines used in the Veterans Health Administration (VHA) caution against benzodiazepine use by veterans with posttraumatic stress disorder (PTSD) because of inefficacy and safety concerns. Although use has declined, the VHA prescription rate is ≥30% nationally. To inform intervention design, this study examined patient- and facility-level correlates of benzodiazepine prescribing. This cross-sectional study used 2009 national administrative VHA data to identify veterans with PTSD, benzodiazepine prescriptions, and various patient and facility characteristics. Correlates of benzodiazepine prescribing were determined with multivariable hierarchical logit models. Among 137 VHA facilities, 495,309 veterans with PTSD were identified, and 150,571 (30.4%) received a benzodiazepine prescription. Patient characteristics independently associated with benzodiazepine use included female gender, age ≥30 years, rural residence, service-connected disability ≥50%, Vietnam-era service, duration of PTSD diagnosis, and a comorbid anxiety disorder. However, case-mix adjustment for these variables accounted for <1% of prescribing variation. Facility characteristics independently associated with higher use included lower PTSD visit volume, higher rates of duplicate prescribing (concurrent use of more than one drug from a class), and lower rates of trazodone prescribing. These findings were corroborated in replication analyses. The ultimate goal is to ensure consistent access to guideline-concordant PTSD treatment across the VHA. This study furthered this objective by identifying characteristics associated with benzodiazepine prescribing. Findings suggest that interventions could be designed to target individual high-volume prescribers or influence prescribing culture at the facility level.Keywords
This publication has 12 references indexed in Scilit:
- Regional Differences in Prescribing Quality Among Elder Veterans and the Impact of Rural ResidenceThe Journal of Rural Health, 2012
- Prescribing Trends in Veterans With Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2012
- Declining Benzodiazepine Use in Veterans With Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2011
- Systemic or intra-amygdala infusion of the benzodiazepine, midazolam, impairs learning, but facilitates re-learning to inhibit fear responses in extinctionLearning & Memory, 2010
- Inappropriate Medication Use as a Risk Factor for Self‐Reported Adverse Drug Effects in Older AdultsJournal of the American Geriatrics Society, 2009
- Tracing the Flow of KnowledgeArchives of General Psychiatry, 2009
- Systemic or intra-amygdala injection of a benzodiazepine (midazolam) impairs extinction but spares re-extinction of conditioned fear responsesLearning & Memory, 2009
- Withdrawing Benzodiazepines in Primary CareCNS Drugs, 2009
- Pharmacotherapy of PTSD in the U.S. Department of Veterans AffairsThe Journal of Clinical Psychiatry, 2008
- Development of a computer algorithm for defining an active drug list using an automated pharmacy databaseJournal of Clinical Epidemiology, 2003